A JAKi in GCA- Phase 3 Results Through 2 Years

Update: 2025-11-09

Description

A JAKi in GCA- Phase 3 Results Through 2 Years

Sponsored by AbbVie Medical Affairs + Health Impact

Comments

In Channel

Tuesday Nite Rheumatology (on 11.18.25)

2025-11-1949:13

Treating During Pregnancy (11.14.2025)

2025-11-1424:44

TNR 11.11.2025 - Replay of RheumNow Live 2025 - Psoriatic Arthritis

2025-11-1446:03

TNR 11.6.2025 - Replay of RheumNow Live 2025 - Rheumatoid Arthritis

2025-11-1454:32

A JAKi in GCA- Phase 3 Results Through 2 Years

2025-11-0918:30

The Interview (11.7.2025)

2025-11-0829:10

ACR 2025 SpA Topic Panel

2025-11-0635:08

ACR 2025 CAR-T Topic Panel

2025-11-0535:11

ACR 2025 RA Topic Panel

2025-11-0454:35

ACR 2025 PsA Topic Panel

2025-11-0331:29

RheumNow Rheumatology Round-Up

2025-10-3159:54

A Halloween ACR Guidance (10.31.25)

2025-10-3104:07

ACR 2025 Daily Podcasts Day4c

2025-10-3008:18

ACR 2025 CAR-T Topic Podcasts Compilation 2

2025-10-3008:38

ACR 2025 SpA Topic Podcasts Compilation 2

2025-10-3027:29

ACR 2025 RA Topic Podcasts Compilation 6

2025-10-3015:34

ACR 2025 PsA Topic Podcasts Compilation 6

2025-10-3017:39

ACR 2025 Daily Podcasts Day4b

2025-10-3025:56

ACR 2025 Daily Podcasts Day4a

2025-10-3042:50

Day 4 Recap- ACR Convergence 2025 Highlights

2025-10-3034:46

00:00

A JAKi in GCA- Phase 3 Results Through 2 Years

#box-pro-ellipsis-176357374566844{-webkit-line-clamp:2;}A JAKi in GCA- Phase 3 Results Through 2 Years

A JAKi in GCA- Phase 3 Results Through 2 Years

Dr. Cush

A JAKi in GCA- Phase 3 Results Through 2 Years